Monte Rosa Therapeutics Inc (GLUE)
6.91
+0.40
(+6.14%)
USD |
NASDAQ |
Dec 20, 16:00
6.915
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Price to Book Value: 2.066 for Dec. 20, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novartis AG | 4.482 |
| MEI Pharma Inc | 0.6696 |
| Evoke Pharma Inc | 1.724 |
| Revance Therapeutics Inc | -- |
| Vera Therapeutics Inc | 9.306 |
Price to Book Value Related Metrics
| Price | 6.91 |
| Earnings Yield | -26.48% |
| Market Cap | 424.53M |